The historical rank and industry rank for Ever Supreme Bio Technology Co's Pretax Margin % or its related term are showing as below:
ROCO:6712'
s Pretax Margin % Range Over the Past 10 Years
Min: -1105.65 Med: 49.34 Max: 90.42
Current: 51.53
ROCO:6712's Pretax Margin % is ranked better than 95.63% of 938
companies
in the Biotechnology industry
Industry Median: -89.895
vs ROCO:6712: 51.53
Ever Supreme Bio Technology Co (ROCO:6712) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Ever Supreme Bio Technology Co Pretax Margin % Related Terms
Ever Supreme Bio Technology Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ever Supreme Bio Technology Co Pretax Margin % Chart
ROCO:6712 vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, Ever Supreme Bio Technology Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ever Supreme Bio Technology Co Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ever Supreme Bio Technology Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Ever Supreme Bio Technology Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ever Supreme Bio Technology Co (ROCO:6712) has a Pretax Margin % of 43.65% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ever Supreme Bio Technology Co and its competitors. This is 12% below median its historical median of 49.34. According to the industry distribution chart, Ever Supreme Bio Technology Co ranks #41 out of 938 companies in the Biotechnology industry, placing it in the top 4.4%.
Is Ever Supreme Bio Technology Co's Pretax Margin % too high?
Ever Supreme Bio Technology Co's current Pretax Margin % of 43.65% is 12% below median its 10-year median of 49.34. Based on the distribution chart, Ever Supreme Bio Technology Co ranks #41 out of 938 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Ever Supreme Bio Technology Co has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ever Supreme Bio Technology Co's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ever Supreme Bio Technology Co ranks #41 out of 938 companies for Pretax Margin %. This places Ever Supreme Bio Technology Co in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ever Supreme Bio Technology Co and its competitors. Ever Supreme Bio Technology Co's current Pretax Margin % is 43.65%, which is 12% below median its own 10-year median of 49.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ever Supreme Bio Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Ever Supreme Bio Technology Co (ROCO:6712) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$212.11, compared to a current price of NT$177.50 — trading 16.3% below its estimated fair value. The current Pretax Margin % is 43.65%, which is 12% below median its 10-year median of 49.34. Ever Supreme Bio Technology Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Ever Supreme Bio Technology Co (ROCO:6712), the current Pretax Margin % is 43.65% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ever Supreme Bio Technology Co (ROCO:6712) Overvalued in 2026?
Based on GuruFocus' analysis, Ever Supreme Bio Technology Co stock appears to be undervalued.
The current stock price of NT$177.50 is trading 16.3% below its estimated GF Value™ of NT$212.11.
GuruFocus considers Ever Supreme Bio Technology Co to be Modestly Undervalued.
Key valuation signals for ROCO:6712:
Pretax Margin %: 43.65% (12% below median its 10-year median of 49.34)
GF Value™: NT$212.11 vs. price of NT$177.50 (16.3% below fair value)
No single metric tells the full story. See the ROCO:6712 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ever Supreme Bio Technology Co Business Description
Ever Supreme Bio Technology Co Ltd is a Taiwan-based company. The company is engaged in research, development, and manufacturing of new drugs related to human mesenchymal stem cells and immune cells. The company operates in two segments: Cell Preparation Business Unit and Other Operating Business. The company gained a majority of revenue from the Cell Preparation Business, which is engaged in the research, development, manufacture, and sales of various new drugs and cell preparations, and investments related to biotechnology and medical industry businesses.
88GF Score
Get the complete analysis for ROCO:6712
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6712 has been successfully added to your 
